Optune Device Approved for Newly Diagnosed Brain Cancer

TUESDAY, Oct. 6, 2015 — The U.S. Food and Drug Administration on Monday expanded its approval for the Optune device to include newly diagnosed glioblastoma multiforme, an aggressive brain cancer.
Optune involves placing electrodes on the surface of…
Source: Topamax